Article
Gait speed and prognosis in idiopathic pulmonary fibrosis
2018-01-01
Abstract excerpt
Background: Idiopathic Pulmonary Fibrosis (IPF) is a progressive disease of the lungs with a median life expectancy of three years. Surrogate endpoints that can predict adverse outcomes are required to help develop and evaluate new treatments for IPF, but existing options have limitations. The four metre gait speed (4MGS) test measures usual walking speed, which in older people is a consistently strong predictor o...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 19333b7a-f5fd-59d8-a50a-bad2b0d5568c
- DOI
- 10.25560/66502
